Table 3.

A logistic regression model of the OR of selected cytokines serum levels and markers of disease activity as predictors of axial spondyloarthritis and inflammatory bowel disease

Covariates	Patients with axSpA and IBD
	OR (95% CI)	p
IL-6 ≥ 6.64 pg/ml	2.25 (0.17–29.05)	0.5
IL-18 ≥ 227.45 pg/ml	1.25 (0.23–6.92)	0.7
ADMA ≥ 9.885 nmol/ml	30.3 (1.50–609.8)	0.02
ET-1 ≤ 1.081 pg/ml	1.08 (0.10–11.52)	0.94
Fetuin-A ≤ 608.5 µg/ml	9.58 (1.47–62.17)	0.01
CRP ≥ 10 mg/L	3.13 (1.12–8.73)	0.02
ESR ≥ 60 mm/h	5.14 (1.35–19.62)	0.01

ADMA asymmetric dimethylarginine, ET-1 endothelin-1, IBD inflammatory bowel disease, IL-6 interleukin-6, IL-18 interleukin-18, OR odds ratio, p p value